ClinicalTrials.gg
Sign In

Eczema clinical trials

The registry lists 503 studies for Eczema across more than 10 countries. 89 are recruiting or about to start. 136 of them are mainly about Eczema (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

ClinicalTrials.gov finds 1,770 studies for Eczema. How that becomes 503 here

This page counts the studies the registry files under Eczema, and those it files under no condition that list Eczemathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,770Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −79List Eczema as a condition, but the registry did not file them under itMost often written as “Atopic Eczema” (23), “Atopic Dermatitis Eczema” (12), and “Eczema, Atopic” (9). The registry filed 1 of them under no condition at all, and the others under other conditions only, most often Dermatitis, Atopic (59) and Kaposi Varicelliform Eruption (6).
  3. −1,188Match it another way40 name it in the title, 23 in a keyword, and 1,125 by a synonym or other text the search reads.
  4. 503The count on this page48 of them list Eczema in their own words; the registry filed them under no condition.

Get an email when these change. Save the Eczema studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
294
Recruiting
67
Status unknown
36
Terminated
36
Active, not recruiting
27
Withdrawn
19

Phase

Phase 2
130
Phase 3
100
Phase 1
37
Phase 4
33
Early Phase 1
2

Where

United States
251
Canada
109
Germany
79
Poland
72
United Kingdom
48
Spain
47

Who runs them

Pfizer (25) · Eli Lilly and Company (22) · LEO Pharma (13) · Regeneron Pharmaceuticals (11) · Incyte Corporation (10) · Arcutis Biotherapeutics, Inc. (9) · National Institute of Allergy and Infectious Diseases (NIAID) (9) · Novartis Pharmaceuticals (8)

What is being tested here

Drugs under test in Eczema studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Abrocitinib3912
Roflumilast214
Tilrekimig223
IMG-007203
Sodium Chloride202
Lebrikizumab11415
Omega-3 fatty acid112
Camoteskimab102
ASLAN004102
Doxycycline101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 4 open · JAK inhibitors 3 open · Calcineurin inhibitors 9 · Corticosteroids 7

Coming up

15phase 3 studies under way
32studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 67 Eczema studies recruiting now, 31 (46%) set no upper age limit and 28 (42%) stop at 75 or younger. 35 (52%) take children under 18. 7 (10%) are for women only and 0 (0%) for men only; 22 (33%) take healthy volunteers.

Recruiting studies that take each age, of 67
AgeWomenMen
1022 (33%)21 (31%)
1851 (76%)45 (67%)
3053 (79%)47 (70%)
4054 (81%)47 (70%)
5052 (78%)48 (72%)
6546 (69%)44 (66%)
7539 (58%)37 (55%)
8537 (55%)35 (52%)

Across all 503 studies, recruiting or not: 47% stop at 75 or younger and 37% at 65; 46% take children; 3% are for women only and <1% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Eczema studies take

Of 71 phase 3 interventional studies under Eczema, half reached primary completion within 18 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 116 mo5–20 · 16 studies——
Phase 214 mo10–26 · 70 studies13 mo9–16 · 54 studies—
Phase 318 mo13–28 · 71 studies18 mo13–26 · 66 studies—
Interventional, no phase11 mo4–26 · 78 studies4 mo2–11 · 33 studies17 mo10–44 · 45 studies
Observational70 mo29–… · 46 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Started recruiting1

Results posted1

Stopped1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 503. Browse all 503 → or search them.